| XGN Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the XGN market cap history going back to 11/2/2020:
Also see: XGN Shares Outstanding History and XGN YTD Return |
XGN Market Cap History — Exagen Capitalization Over Time
As of 4/30/2026 Exagen has a market cap of 72.89 million. Investors often follow the XGN market cap history to compare the size of the company over time.
This page shows XGN market capitalization trends over time, with 27 market cap datapoints presented, dating back to 11/2/2020.
| XGN Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
XGN Historical Market Cap: -41.53% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| XGN Stock Price Chart |
| About Exagen Inc |
| Exagen Inc. is a provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision-making. Co. has developed and is commercializing a portfolio of testing products, under its AVISE brand. It commercially launched its testing product, AVISE CTD, which enables differential diagnosis for patients presenting with symptoms indicative of a variety of connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The comprehensive nature of AVISE CTD allows for the testing of various relevant biomarkers in one convenient blood draw. We show 27 historical shares outstanding datapoints in our XGN shares outstanding history coverage, used to compute XGN market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing XGN market cap history over the course of time is important for investors interested in comparing XGN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of XGN versus a peer is one thing; comparing XGN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like XGN can fluctuate over the course of history. With this page we aim to empower investors researching XGN by allowing them to research the XGN market cap history. |
| XGN Current Stock Quote |
Quotes delayed 20 minutes  Free XGN Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| XGN Share Performance |
| Market Cap Peers |
| Exagen (XGN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
XLO Market Cap History XLRN Market Cap History XNCR Market Cap History XOMA Market Cap History XON Market Cap History XRAY Market Cap History YMAB Market Cap History YMTX Market Cap History YTEN Market Cap History ZBH Market Cap History More Healthcare companies » |
XGN Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
